Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Assets Average (2016 - 2025)

Historic Assets Average for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $170.7 million.

  • Fortress Biotech's Assets Average rose 2512.45% to $170.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.7 million, marking a year-over-year increase of 2512.45%. This contributed to the annual value of $155.9 million for FY2024, which is 3249.66% down from last year.
  • As of Q3 2025, Fortress Biotech's Assets Average stood at $170.7 million, which was up 2512.45% from $169.0 million recorded in Q2 2025.
  • Fortress Biotech's Assets Average's 5-year high stood at $413.0 million during Q3 2021, with a 5-year trough of $135.7 million in Q4 2024.
  • Over the past 5 years, Fortress Biotech's median Assets Average value was $222.1 million (recorded in 2023), while the average stood at $260.1 million.
  • Per our database at Business Quant, Fortress Biotech's Assets Average surged by 6270.84% in 2021 and then crashed by 5181.67% in 2023.
  • Quarter analysis of 5 years shows Fortress Biotech's Assets Average stood at $402.2 million in 2021, then dropped by 23.18% to $308.9 million in 2022, then plummeted by 48.52% to $159.0 million in 2023, then decreased by 14.7% to $135.7 million in 2024, then rose by 25.8% to $170.7 million in 2025.
  • Its Assets Average stands at $170.7 million for Q3 2025, versus $169.0 million for Q2 2025 and $161.1 million for Q1 2025.